What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

The 340B Program Has Changed. Your Infrastructure Should Too.

The 340B Program Has Changed. Your Infrastructure Should Too.

340B has evolved from a purchasing program into a complex financial reimbursement ecosystem. New policies demand a new financial operating system.

Tungsten+PLUS™ is the end-to-end platform built to manage the complete 340B reimbursement lifecycle, from identifying eligible transactions and meeting manufacturer requirements to collecting reimbursements, reconciling payments, resolving discrepancies, and intelligently identifying, filing, tracking, and resolving Good Faith Inquiries (GFIs).

Tungsten+PLUS™ delivers:

  • A financial operations backbone for MFP, the 340B Rebate Model, and manufacturer claims-level submissions
  • End-to-end automation, from transaction identification through submission, reimbursement, reconciliation, and resolution
  • Intelligent GFI identification, filing, tracking, and resolution
  • Automated payment reconciliation and discrepancy resolution
  • Complete financial visibility and continuous audit readiness
  • Proven expertise backed by more than 20 years of experience in rebate administration and 340B program management

Tungsten+PLUS™ is more than workflow automation. It connects and administers the entire 340B financial lifecycle, automating every stage from eligible transaction identification to final payment and dispute resolution.

One connected platform. One automated financial lifestyle. Tunsten+PLUS™: The Financial Operating System for 340B.

RxParadigm

RxParadigm News & Announcements

RxParadigm is a pharmacy technology solutions company founded by experts in drug-pricing transparency, rebate administration, and 340B compliance. Powered by the Tungsten+PLUS™ platform and a centralized 340B Clearinghouse data management system, RxParadigm delivers transparency, compliance, and operational efficiency across the drug supply chain. The platform is purpose-built to support Medicare Maximum Fair Price (MFP) effectuation and the implementation of rebate-based models, while ensuring the integrity, transparency, and sustainability of the 340B program in an equitable manner for all stakeholders. Tungsten+PLUS™ eliminates duplicate payments, enables efficient and auditable dispute resolution, preserves patient access, and safeguards overall program integrity.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from The 340B Program Has Changed. Your Infrastructure Should Too.

Name
Address
Subscribe